卡维迪洛尔通过抑制NLRP3炎症酶来改善实验性动脉样硬化
Hong Xu1, Rui Xu2, Kaixin Yan2
1Gerontology Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China - dengta2022@126.com.
Minerva cardiology and angiology
|October 1, 2024
概括
卡维迪洛尔通过抑制NLRP3炎症酶来预防动脉样硬化. 这项研究证明了卡维迪醇的存在.
科学领域:
- 心血管研究研究心血管研究
- 炎症生物学 炎症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉样硬化是一种慢性炎症性疾病.
- NLRP3炎症酶在动脉样硬化病变发生过程中起着关键作用.
- 卡维迪洛尔对动脉样硬化的保护作用尚未完全理解.
研究的目的:
- 为了研究卡维迪醇对动脉样硬化的保护作用.
- 为了确定卡维迪洛是否抑制NLRP3炎症酶通路.
主要方法:
- 使用人类静脉内皮细胞 (HUVEC) 的体外研究.
- 细胞被用ox-LDL和不同度的卡维迪醇处理.
- 通过CCK-8,油红色O染色,ELISA和西部斑点,分析了细胞增殖,脂质液滴形成和NLRP3炎症组分 (NLRP3,Caspase-1,IL-1β,GSDMD) 的表达.
主要成果:
- 氧-LDL降低了HUVEC的扩散,增加了脂质的积累.
- 卡维迪洛尔的预处理 (尤其是5μM) 显著改善了细胞增殖和减少了脂质滴.
- 卡维迪醇和MCC950 (NLRP3抑制剂) 降低了ox-LDL处理的HUVEC中的NLRP3炎症酶激活标志物.
结论:
- 卡维迪洛在体外显示出对动脉样硬化进展的显著保护作用.
- 卡维迪洛尔通过向和抑制NLRP3炎症酶通路来抑制动脉样硬化.
- 这些发现为卡维迪洛在动脉样硬化心血管疾病的治疗潜力提供了机械的见解.
相关概念视频
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
462
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
462
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
419
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
419
01:16Antianginal Drugs: Nitrates and β-Blockers
537
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
537
01:22Heart Failure Drugs: β-Blockers
320
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
320
01:26Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
01:23Antihypertensive Drugs: Vasodilators
490
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
490